{"id":"W4394853075","doi":"10.1002/psp4.13141","title":"Population pharmacokinetics and exposure–response analyses of polatuzumab vedotin in patients with previously untreated <scp>DLBCL</scp> from the <scp>POLARIX</scp> study","year":2024,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"F. Hoffmann-La Roche","keywords":"Medicine; Internal medicine; Brentuximab vedotin; Rituximab; Adverse effect; Pharmacokinetics; Oncology; Population; Cyclophosphamide; Dosing; Pharmacology; Gastroenterology; Lymphoma; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001142942,0.0006894602,0.001329356,0.001927387,0.0001658867,0.000152772,0.0003531484,0.0002103409,0.00003170356],"category_scores_gemma":[0.0005510402,0.0004657476,0.0001839293,0.004621753,0.0001507571,0.0002583512,0.0001950742,0.0005701139,0.00002528601],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006777337,"about_ca_system_score_gemma":0.0002738866,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002188813,"about_ca_topic_score_gemma":0.00001788306,"domain_scores_codex":[0.9943933,0.00155159,0.001343066,0.0009834138,0.0009703661,0.0007582276],"domain_scores_gemma":[0.991699,0.006514321,0.0005217338,0.0004461309,0.0004051831,0.0004135962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005516734,0.004535275,0.9737195,0.0002948408,0.003178285,0.0004651535,0.002537883,0.0003743781,0.008713637,0.000006494863,0.003610402,0.002012411],"study_design_scores_gemma":[0.02827705,0.00273459,0.9485396,0.0002588029,0.004442752,0.00003730686,0.0009047303,0.002987411,0.007242082,0.00000368555,0.004453976,0.000118021],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9538441,0.03984005,0.00002358913,0.00007528499,0.001543942,0.004149023,0.0002863273,0.0001596373,0.00007807971],"genre_scores_gemma":[0.9972437,0.001225001,0.00004732909,0.000262302,0.0003263163,0.00035074,0.0002858019,0.0001083761,0.0001504235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04339964,"threshold_uncertainty_score":0.9997794,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02628133640088636,"score_gpt":0.3321197062955578,"score_spread":0.3058383698946714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}